Oral epithelial cells play a critical role in innate mucosal immunity. To maintain tissue integrity, the cells undergo a differentiation resulting in the expression of keratins. Epithelial cells also produced antimicrobial peptides including human ?-defensins (hBDs) and secretory leukocyte protease inhibitor (SLPI), and cytokines that play significant roles in the regulation of oral infection. Since prevalence of oral candidiasis is decreased, but oral wart is increased with use of antiretroviral therapy (ART), the immune reconstitution and immune response at mucosal sites may differentially affect epithelial function in defense against infection. It is not known if long-term use of ART can alter epithelial differentiation, structure and function in oral innate immunity. Therefore, the overall objective of this study is to determine changes in expression of keratins, hBD2, and SLPI mRNA and their salivary proteins, as well as oral tissue cytokine profiles and salivary cytokine levels in HIV-infected patients with ART compared with those without ART, and non-HIV healthy subjects. The study is comprised of three aims: 1) To determine changes in epithelial structure and pattern of keratin expression by long term use of ART, 2) to determine if hBD2 and SLPI expression in oral epithelial tissue and saliva are affected by long term use of ART, and 3) to determine changes in pro-inflammatory cytokine profiles in oral epithelial tissues and saliva by long term use of ART. One hundred HIV subjects on ART will be enrolled. One hundred HIV subjects without ART with the same range of CD4 count and viral load, and 50 non-HIV healthy subjects with match age and gender will serve as controls. History taking and oral examination will be performed. Tissue biopsy using an 8-mm diameter punch on oral buccal mucosa will be conducted. One half of the tissue will be stained by hematoxylin and eosin (H&E) and immunohistochemistry method. Pattern of keratin expression will be analyzed and correlated with the use of ART. The other half of the tissue will be used for RNA isolation. The expression of hBD2 and SLPI mRNA will be determined by using a reverse transcriptase polymerase chain reaction (RT-PCR) amplification assay and Quantitative Polymerase Chain Reaction (Real-Time PCR) assay. Whole saliva will be collected, and salivary levels of hBD2 and SLPI proteins will be determined by using enzyme-linked immunosorbent assay (ELISA). Expression of hBD2 and SLPI mRNA in tissue, and their salivary protein levels will be correlated with the advent of ART. Cytokine profiles in tissue from selected representative subjects will be analyzed by microarray. Levels of cytokines of interest in saliva will be determined by ELISA. Salivary cytokine profiles involved in oral innate immunity against Candida and human papilloma virus will be analyzed. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DE018340-02
Application #
7487008
Study Section
Special Emphasis Panel (ZDE1-PZ (19))
Program Officer
Rodriguez-Chavez, Isaac R
Project Start
2007-09-01
Project End
2010-08-31
Budget Start
2008-09-01
Budget End
2010-08-31
Support Year
2
Fiscal Year
2008
Total Cost
$186,921
Indirect Cost
Name
Prince of Songkla University
Department
Type
DUNS #
659454917
City
Hat Yai, Songkhla
State
Country
Thailand
Zip Code
90110
Nittayananta, Wipawee; Tao, Renchuan; Jiang, Lanlan et al. (2016) Oral innate immunity in HIV infection in HAART era. J Oral Pathol Med 45:3-8
Nittayananta, W; Amornthatree, K; Kemapunmanus, M et al. (2014) Expression of oral cytokines in HIV-infected subjects with long-term use of antiretroviral therapy. Oral Dis 20:e57-64
Nittayananta, Wipawee; Kemapunmanus, Marisa; Yangngam, Supaporn et al. (2013) Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy. J Oral Pathol Med 42:208-15
Nittayananta, Wipawee; Kemapunmanus, Marisa; Amornthatree, Korntip et al. (2013) Oral human ?-defensin 2 in HIV-infected subjects with long-term use of antiretroviral therapy. J Oral Pathol Med 42:53-60
Amornthatree, Korntip; Sriplung, Hutcha; Mitarnun, Winyou et al. (2012) Effects of long-term use of antiretroviral therapy on the prevalence of oral Epstein-Barr virus. J Oral Pathol Med 41:249-54
Amornthatree, Korntip; Sriplung, Hutcha; Mitarnun, Winyou et al. (2012) Impacts of HIV infection and long-term use of antiretroviral therapy on the prevalence of oral human papilloma virus type 16. J Oral Pathol Med 41:309-14
Nittayananta, W; Mitarnun, W; Talungchit, S et al. (2012) Changes in oral cytokeratin expression in HIV-infected subjects with long-term use of HAART. Oral Dis 18:793-801
Nittayananta, Wipawee; Talungchit, Sineepat; Jaruratanasirikul, Sutep et al. (2010) Effects of long-term use of HAART on oral health status of HIV-infected subjects. J Oral Pathol Med 39:397-406